Source link : https://www.newshealth.biz/health-news/fda-approves-third-tocilizumab-biosimilar/
The US Food and Drug Administration (FDA) has approved Avtozma (tocilizumab-anoh) as a biosimilar of the original reference biologic tocilizumab (Actemra), according to a January 30 announcement from its manufacturer, Celltrion. Avtozma, an anti-interleukin 6 receptor antagonist, is approved for all of the same indications as reference tocilizumab (Actemra) — rheumatoid arthritis (RA), giant cell […]
Author : News Health
Publish date : 2025-02-03 07:43:50
Copyright for syndicated content belongs to the linked Source.
inHealth